Levine Leichtman-backed Therapeutics Research Center acquires NetCE

Levine Leichtman invested in Therapeutics Research Center through its fifth fund. 

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this